The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor
Abstract
CP-96,345 [(2 S , 3 S )- cis -2-(diphenylmethyl)- N -[(2-methoxyphenyl)-methyl]-1-azabicyclo[2.2.2]octan-3-amine] is a potent nonpeptide antagonist of the substance P (NK 1 ) receptor. CP-96,345 inhibited 3 H-labeled substance P binding and was a classical competitive antagonist in the NK 1 monoreceptor dog carotid artery preparation. CP-96,345 inhibited substance P-induced salivation in the rat, a classical in vivo bioassay, but did not inhibit NK 2 , NK 3 , or numerous other receptors; it is thus a selective NK 1 antagonist. This compound may prove to be a powerful tool for investigation of the physiological properties of substance P and exploration of its role in diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O., & SCHILD, H. O. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00928.x · Cited by 3,938
An unidentified depressor substance in certain tissue extracts
v. Euler, U. S., & Gaddum, J. H. (1931) · The Journal of Physiology · doi:10.1113/jphysiol.1931.sp002763 · Cited by 1,578
Substance P: Localization in the Central Nervous System and in Some Primary Sensory Neurons
Hökfelt, T., Kellerth, J. O., Nilsson, G., & Pernow, B. (1975) · Science · doi:10.1126/science.242075 · Cited by 1,025
Chang, M. M., & Leeman, S. E. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62860-1 · Cited by 696
Maggio, J. E. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.000305 · Cited by 547
Substance P as a Transmitter Candidate
Nicoll, R. A., Schenker, C., & Leeman, S. E. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.001303 · Cited by 528
Substance P Activation of Rheumatoid Synoviocytes: Neural Pathway in Pathogenesis of Arthritis
Lotz, M., Carson, D. A., & Vaughan, J. H. (1987) · Science · doi:10.1126/science.2433770 · Cited by 444
New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization
Regoli, D. C., Drapeau, G., Dion, S., et al. (1988) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(88)90013-2 · Cited by 358
Substance P: binding properties and studies on cellular responses in guinea pig macrophages.
Hartung, H. P., Wolters, K., & Toyka, K. V. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.10.3856 · Cited by 256
Cited by
Coderre, T. J., Katz, J., Vaccarino, A. L., & Melzack, R. (1993) · Pain · doi:10.1016/0304-3959(93)90161-h · Cited by 1,966
Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Van Gompel, P., Lesage, A. S., De Loore, K., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors
Kramer, M. S., Cutler, N., Feighner, J., Shrivastava, R., Carman, J., Sramek, J. J., Reines, S. A., Liu, G., Snavely, D., Wyatt-Knowles, E., et al. (1998) · Science · doi:10.1126/science.281.5383.1640 · Cited by 1,071
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
Giannis, A., & Kolter, T. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199312441 · Cited by 784
Wind-up of spinal cord neurones and pain sensation: much ado about something?
Herrero, J. F., Laird, J. M. A., & Lopez-Garcia, J. A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00051-9 · Cited by 714
Tachykinin receptors and tachykinin receptor antagonists
Maggi, C. A., Patacchini, R., Rovero, P., & Giachetti, A. (1993) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1993.tb00396.x · Cited by 636
Neuropeptides in perspective: The last ten years
Hökfelt, T. (1991) · Neuron · doi:10.1016/0896-6273(91)90333-u · Cited by 618
Hökfelt, T., Broberger, C., Xu, Z.-Q. D., Sergeyev, V., Ubink, R., & Diez, M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00010-1 · Cited by 604
The mammalian tachykinin receptors
Maggi, C. A. (1995) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(94)00292-u · Cited by 486
Maggi, C. A. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(94)e0017-b · Cited by 470
Bradykinin receptors: Pharmacological properties and biological roles
Hall, J. M. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90016-s · Cited by 451
Neuropeptides in the Respiratory Tract: Part I
Barnes, P. J., Baraniuk, J. N., & Belvisi, M. G. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1187 · Cited by 450
A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptor
Emonds-Alt, X., Vilain, P., Goulaouic, P., Proietto, V., Van Broeck, D., Advenier, C., Naline, E., Neliat, G., Le Fur, G., & Breliére, J. C. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90352-p · Cited by 434
Pharmacological properties of a potent and selective nonpeptide substance P antagonist.
Garret, C., Carruette, A., Fardin, V, Moussaoui, S., Peyronel, J. F., Blanchard, J. C., & Laduron, P. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10208 · Cited by 425
Whitebread, S., Hamon, J., Bojanic, D., & Urban, L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03632-9 · Cited by 404
Yeomans, D. C., Pirec, V., & Proudfit, H. K. (1996) · Pain · doi:10.1016/s0304-3959(96)03176-4 · Cited by 391
Emonds-Alt, X., Doutremepuich, J.-D., Heaulme, M., Neliat, G., Santucci, V., Steinberg, R., Vilain, P., Bichon, D., Ducoux, J.-P., Proietto, V., et al. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90027-f · Cited by 370
Origin and evolution of high throughput screening
Pereira, D. A., & Williams, J. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707373 · Cited by 364
Substance P: a pioneer amongst neuropeptides
Hökfelt, T., Pernow, B., & Wahren, J. (2001) · Journal of Internal Medicine · doi:10.1046/j.0954-6820.2000.00773.x · Cited by 346
Tachykinins in the gut. Part I. Expression, release and motor function
Holzer, P., & Holzer-Petsche, U. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00195-7 · Cited by 310
The role of substance P in stress and anxiety responses
Ebner, K., & Singewald, N. (2006) · Amino Acids · doi:10.1007/s00726-006-0335-9 · Cited by 306
Chapter 26. Privileged structures — An update
Patchett, A. A., & Nargund, R. P. (2000) · Annual Reports in Medicinal Chemistry · doi:10.1016/s0065-7743(00)35027-8 · Cited by 302
Central hyperexcitability triggered by noxious inputs
McMahon, S. B., Lewin, G. R., & Wall, P. D. (1993) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(93)90062-4 · Cited by 288
Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists
Rupniak, N. M. J., & Kramer, M. S. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01396-6 · Cited by 276
Tachykinins: receptor to effector
Khawaja, A. M., & Rogers, D. F. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(96)00017-9 · Cited by 257
Douglas, S. D., & Leeman, S. E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05826.x · Cited by 200
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3702 · Cited by 194
Neuropeptides as synaptic transmitters
Salio, C., Lossi, L., Ferrini, F., & Merighi, A. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0268-3 · Cited by 181
Hargreaves, R., Ferreira, J. C. A., Hughes, D., Brands, J., Hale, J., Mattson, B., & Mills, S. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.05961.x · Cited by 102
Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting
Ruhlmann, C. H., & Herrstedt, J. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.199 · Cited by 16
Metadata
- Authors
- Snider, R. M., Constantine, J. W., Lowe, J. A., Longo, K. P., Lebel, W. S., Woody, H. A., Drozda, S. E., Desai, M. C., Vinick, F. J., Spencer, R. W., & Hess, H.-J.
- Venue
- Science
- Published
- 1991-01-25
- Volume
- 251
- Issue
- 4992
- Pages
- 435-437
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2031706219
- Cited by
- 859
- References
- 18
- FWCI
- 47.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.